Yahoo
Tokyo - Delayed Quote JPY

CUC Inc. (9158.T)

623.00 +11.00 (+1.80%)
As of 9:38:06 AM GMT+9. Market Open.
Chart Range Bar
Loading chart for 9158.T
  • Previous Close 612.00
  • Open 612.00
  • Bid --
  • Ask --
  • Day's Range 612.00 - 626.00
  • 52 Week Range 601.00 - 1,071.00
  • Volume 149,300
  • Avg. Volume 42,549
  • Market Cap (intraday) 18.263B
  • Beta (5Y Monthly) 0.18
  • PE Ratio (TTM) 8.38
  • EPS (TTM) 73.01
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 800.00
  • Moby Rating Neutral

CUC Inc. offers healthcare services in Japan and internationally. It provides medical institution operations support, including strategic, administrative, marketing, HR/recruiting, and procurement support, as well as support for IT, accounting, general affairs, etc.; medical institution revenue growth assistance services, such as M and A, post-merger integration, hospital bed conversion, and clinic launches; and medical institution cost optimization support. The company also provides meals to hospitals, welfare facilities, and hospice facilities; and leases and maintains real estate for medical institutions. In addition, it operates a hospice specializing in care for people in the terminal stages of cancer or with intractable diseases, as well as a home nursing and care business under the ReHOPE brand name. Further, the company offers home nursing; day care services, in-home nursing care support; and in-home clinical trials and in-home monitoring services. The company provides its support service to in-home, hospital, dialysis, and outpatient care. The company was incorporated in 2014 and is headquartered in Minato, Japan. CUC Inc. is a subsidiary of M3 Inc.

www.cuc-jpn.com

5,740

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

9158.T
27.83%
Nikkei 225 (^N225)
14.09%

1-Year Return

9158.T
39.41%
Nikkei 225 (^N225)
12.87%

3-Year Return

9158.T
78.14%
Nikkei 225 (^N225)
75.60%

5-Year Return

9158.T
86.19%
Nikkei 225 (^N225)
93.96%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 14.58B
Earnings 180M
Profit Margin 1.23%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
5B
10B
0.0%
2.0%
4.0%
6.0%
8.0%
10.0%

Analyst Insights

View More

Analyst Price Targets

800.00
800.00 Average
623.00 Current
800.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.77%

  • Return on Assets (ttm)

    3.22%

  • Return on Equity (ttm)

    5.98%

  • Revenue (ttm)

    56.8B

  • Net Income Avi to Common (ttm)

    2.14B

  • Diluted EPS (ttm)

    73.01

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    16.12B

  • Total Debt/Equity (mrq)

    162.80%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: